Ventas, Inc. (VTR) Stake Decreased by Cigna Investments Inc. New
Cigna Investments Inc. New cut its stake in Ventas, Inc. (NYSE:VTR) by 5.1% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 13,673 shares of the real estate investment trust’s stock after selling 736 shares during the period. Cigna Investments Inc. New’s holdings in Ventas were worth $950,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Cribstone Capital Management LLC acquired a new position in Ventas during the first quarter valued at about $123,000. Benjamin F. Edwards & Company Inc. boosted its position in Ventas by 2.7% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 2,436 shares of the real estate investment trust’s stock valued at $158,000 after buying an additional 65 shares during the last quarter. Wagner Bowman Management Corp acquired a new position in Ventas during the first quarter valued at about $201,000. Trust Co. of Virginia VA acquired a new position in Ventas during the first quarter valued at about $202,000. Finally, Honkamp Krueger Financial Services Inc. acquired a new position in Ventas during the second quarter valued at about $203,000. 88.70% of the stock is owned by institutional investors.
Shares of Ventas, Inc. (NYSE VTR) opened at 64.95 on Friday. Ventas, Inc. has a one year low of $56.20 and a one year high of $74.67. The stock’s 50 day moving average price is $67.88 and its 200 day moving average price is $65.25. The stock has a market capitalization of $23.13 billion, a P/E ratio of 32.90 and a beta of 0.07.
Ventas (NYSE:VTR) last announced its quarterly earnings data on Friday, July 28th. The real estate investment trust reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.61. Ventas had a return on equity of 6.31% and a net margin of 20.08%. The business had revenue of $895.49 million during the quarter, compared to analysts’ expectations of $890.01 million. During the same period in the previous year, the firm earned $0.42 earnings per share. The firm’s quarterly revenue was up 5.6% compared to the same quarter last year. On average, analysts forecast that Ventas, Inc. will post $1.84 EPS for the current year.
TRADEMARK VIOLATION WARNING: “Ventas, Inc. (VTR) Stake Decreased by Cigna Investments Inc. New” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://theolympiareport.com/2017/08/12/ventas-inc-vtr-stake-decreased-by-cigna-investments-inc-new.html.
Several research analysts have recently issued reports on VTR shares. BidaskClub cut Ventas from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 8th. Jefferies Group LLC increased their price target on Ventas from $61.00 to $64.00 and gave the stock a “hold” rating in a research note on Monday, May 1st. Mitsubishi UFJ Financial Group started coverage on Ventas in a research note on Wednesday, June 21st. They issued a “hold” rating and a $67.00 price target for the company. Finally, Mizuho reissued a “neutral” rating on shares of Ventas in a research note on Wednesday, June 28th. Five research analysts have rated the stock with a sell rating and eight have assigned a hold rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $65.13.
In related news, Chairman Debra A. Cafaro sold 100,000 shares of Ventas stock in a transaction on Thursday, June 15th. The stock was sold at an average price of $69.12, for a total transaction of $6,912,000.00. Following the completion of the sale, the chairman now directly owns 819,835 shares of the company’s stock, valued at $56,666,995.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.30% of the stock is owned by insiders.
Ventas, Inc is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses.
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR).
Receive News & Ratings for Ventas Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.